CLBTNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Cellebrite DI Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 3, 2026
$11.14+0.12 (+1.04%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 36.0
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2018 to 2025
Gross margin
84.2%+3.6 pts over 5 years
Operating margin
14.0%+9.2 pts over 5 years
Net margin
16.5%+13.5 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +18.6% | +20.7% | +19.5% | – | |
| Gross profit | +18.3% | +22.1% | +20.6% | – | |
| Operating income | +16.8% | +299.3% | +48.5% | – | |
| Net income | – | -13.4% | +68.4% | – | |
| EPS, diluted | – | -19.3% | – | – | |
| Free cash flow | +29.7% | +127.1% | +21.6% | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 9.4% | 19.1% | |
| Return on assets | – | – | 9.6% | |
| Current ratio | – | 2.03 | 1.56 | |
| Inventory turnover | – | – | 9.1× | |
| Capex to revenue | – | 3.2% | 2.8% | |
| Diluted shares | – | 124M | 250M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Cellebrite DI generated $464.40M from operations and spent $139.03M on capital expenditure, dividends and share buybacks. 28% of that went back into the business.
Generated
$464.40M
Used
$139.03M
Capital expenditure$39.03M28%Dividends$100.00M72%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin16.5%
×Asset turnover0.58×
×Equity multiplier1.99×
=Return on equity, FY202519.1%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 16.5% | 0.58× | 1.99× | 19.1% |
| FY2024 | -70.5% | 0.66× | 3.30× | -152.9% |
| FY2023 | -24.9% | 0.69× | 8.66× | -150.1% |
| FY2022 | 44.6% | 0.73× | 1434.51× | 46642.9% |
| FY2021 | 29.0% | 0.70× | -73.79× | -1496.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$78.33M
- Cash generatingOperating cash flow above zero$173.54M
- Return on assets improvedROA up on the prior year-53.1% → 11.3%
- Earnings backed by cashOperating cash flow above net income$173.54M vs $78.33M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.92 → 1.56
- No dilutionShare count did not rise209M → 250M
- Gross margin improvedGross margin up on the prior year84.40% → 84.20%
- More efficientAsset turnover rose0.75 → 0.69